[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.167.142.229. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Correspondence
June 2005

0.1% Tacrolimus Ointment for the Treatment of Intertrigo

Arch Dermatol. 2005;141(6):787. doi:10.1001/archderm.141.6.787-a

Intertrigo is a combination of infectious, mechanical, and inflammatory changes of the skin folds that can be recurrent and chronic. Friction between skin folds and increased moisture promote an irritated cutaneous environment that increases the chance of infection. The combination of these factors leads to an inflammatory process.

Historically, medium- to mild-potency topical steroids were prescribed for quick resolution of these inflammatory changes, but continued long-term therapy is sometimes required. This is not optimal because of atrophy and striae formation, especially in the intertriginous areas, associated with long-term topical steroid use. Thus, we used a nonsteroidal topical ointment, 0.1% tacrolimus, for 6 weeks in 10 patients with intertrigo.

First Page Preview View Large
First page PDF preview
First page PDF preview
×